 SAN DIEGO, March 16, 2021 GLOBE NEWSWIRE -- Guardion Health Sciences, Inc. Nasdaq: GHSI Guardion or the Company, a clinical nutrition and diagnostics company that develops clinically supported nutritional supplements, medical foods, and medical devices, announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market pursuant to Listing Rule 5550a2 the Minimum Bid Price Rule. On March 15, 2021, Guardion received a letter from the Office of General Counsel of The Nasdaq Stock Market LLC Nasdaq stating that because Guardions Companys common stock the Common Stock had a closing bid price at or above 1.00 per share for a minimum of ten 10 consecutive trading days, its Common Stock had regained compliance with Nasdaqs Minimum Bid Price Rule. 